[1] |
Mushahary D, Spittler A, Kasper C, et al. Isolation, cultivation, and characterization of human mesenchymal stem cells[J]. Cytometry A, 2018,93(1):19⁃31. doi: 10.1002/cyto.a.23242.
|
[2] |
Chaudhary D, Trivedi RN, Kathuria A, et al. In vitro and In vivo immunomodulating properties of mesenchymal stem cells[J]. Recent Pat Inflamm Allergy Drug Discov, 2018,12(1):59⁃68. doi: 10.2174/1872213X12666180227105924.
|
[3] |
Friedenstein AJ, Petrakova KV, Kurolesova AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues[J]. Transplantation, 1968,6(2):230⁃247.
|
[4] |
Andrzejewska A, Lukomska B, Janowski M. Concise review: mesenchymal stem cells: from roots to boost[J]. Stem Cells, 2019,37(7):855⁃864. doi: 10.1002/stem.3016.
|
[5] |
Campanati A, Consales V, Orciani M, et al. Role of mesenchymal stem cells in the pathogenesis of psoriasis: current perspectives[J]. Psoriasis (Auckl), 2017,7:73⁃85. doi: 10.2147/PTT.S108311.
|
[6] |
Wang Q, Yang Q, Wang Z, et al. Comparative analysis of human mesenchymal stem cells from fetal⁃bone marrow, adipose tissue, and Warton′s jelly as sources of cell immunomodulatory therapy[J]. Hum Vaccin Immunother, 2016,12(1):85⁃96. doi: 10.1080/21645515.2015.1030549.
|
[7] |
Bougioukli S, Saitta B, Sugiyama O, et al. Lentiviral gene therapy for bone repair using human umbilical cord blood⁃derived mesenchymal stem cells[J]. Hum Gene Ther, 2019,30(7):906⁃917. doi: 10.1089/hum.2018.054.
|
[8] |
Damia E, Chicharro D, Lopez S, et al. Adipose⁃derived mesenchymal stem cells: are they a good therapeutic strategy for osteoarthritis?[J]. Int J Mol Sci, 2018,19(7):1926. doi: 10.3390/ijms19071926.
|
[9] |
Kern S, Eichler H, Stoeve J, et al. Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue[J]. Stem Cells, 2006,24(5):1294⁃1301. doi: 10.1634/stemcells.2005⁃0342.
|
[10] |
Ayala⁃Cuellar AP, Kang JH, Jeung EB, et al. Roles of mesenchymal stem cells in tissue regeneration and immunomodulation[J]. Biomol Ther (Seoul), 2019,27(1):25⁃33. doi: 10.4062/biomolther.2017.260.
|
[11] |
韩齐心, 牛旭平, 刘佳, 等. 间充质干细胞及其外泌体与Th17/Treg对银屑病发病机制的研究进展[J]. 中华皮肤科杂志, 2020,53(2):151⁃154. doi: 10.35541/cjd.20190012.
|
[12] |
Wang Y, Tian M, Wang F, et al. Understanding the immunological mechanisms of mesenchymal stem cells in allogeneic transplantation: from the aspect of major histocompatibility complex class I[J]. Stem Cells Dev, 2019,28(17):1141⁃1150. doi: 10.1089/scd.2018.0256.
|
[13] |
Bonfield TL, Nolan Koloze MT, Lennon DP, et al. Defining human mesenchymal stem cell efficacy in vivo[J]. J Inflamm (Lond), 2010,7:51. doi: 10.1186/1476⁃9255⁃7⁃51.
|
[14] |
Sah SK, Park KH, Yun CO, et al. Effects of human mesenchymal stem cells transduced with superoxide dismutase on imiquimod⁃induced psoriasis⁃like skin inflammation in mice[J]. Antioxid Redox Signal, 2016,24(5):233⁃248. doi: 10.1089/ars.2015.6368.
|
[15] |
Lee YS, Sah SK, Lee JH, et al. Human umbilical cord blood⁃derived mesenchymal stem cells ameliorate psoriasis⁃like skin inflammation in mice[J]. Biochem Biophys Rep, 2017,9:281⁃288. doi: 10.1016/j.bbrep.2016.10.002.
|
[16] |
Kim JY, Park M, Kim YH, et al. Tonsil⁃derived mesenchymal stem cells (T⁃MSCs) prevent Th17⁃mediated autoimmune response via regulation of the programmed death⁃1/programmed death ligand⁃1 (PD⁃1/PD⁃L1) pathway[J]. J Tissue Eng Regen Med, 2018,12(2):e1022⁃e1033. doi: 10.1002/term.2423.
|
[17] |
Imai Y, Yamahara K, Hamada A, et al. Human amnion⁃derived mesenchymal stem cells ameliorate imiquimod⁃induced psoriasiform dermatitis in mice[J]. J Dermatol, 2019,46(3):276⁃278. doi: 10.1111/1346⁃8138.14768.
|
[18] |
刘瑞风, 杨晓红, 梁见楠, 等. 银屑病患者皮损间充质干细胞环状RNA表达异常研究[J]. 中华皮肤科杂志, 2018,51(10):723⁃728. doi: 10.3760/cma.j.issn.0412⁃4030.2018.10.004.
|
[19] |
Liu R, Chang W, Li J, et al. Mesenchymal stem cells in psoriatic lesions affect the skin microenvironment through circular RNA[J]. Exp Dermatol, 2019,28(3):292⁃299. doi: 10.1111/exd.13890.
|
[20] |
Liu R, Wang Q, Chang W, et al. Characterisation of the circular RNA landscape in mesenchymal stem cells from psoriatic skin lesions[J]. Eur J Dermatol, 2019,29(1):29⁃38. doi: 10.1684/ejd. 2018.3483.
|
[21] |
Campanati A, Orciani M, Consales V, et al. Characterization and profiling of immunomodulatory genes in resident mesenchymal stem cells reflect the Th1⁃Th17/Th2 imbalance of psoriasis[J]. Arch Dermatol Res, 2014,306(10):915⁃920. doi: 10.1007/s00403⁃ 014⁃1493⁃3.
|
[22] |
Hou R, Yin G, An P, et al. DNA methylation of dermal MSCs in psoriasis: identification of epigenetically dysregulated genes[J]. J Dermatol Sci, 2013,72(2):103⁃109. doi: 10.1016/j.jdermsci. 2013.07.002.
|
[23] |
Orciani M, Campanati A, Salvolini E, et al. The mesenchymal stem cell profile in psoriasis[J]. Br J Dermatol, 2011,165(3):585⁃592. doi: 10.1111/j.1365⁃2133.2011.10438.x.
|
[24] |
Liu R, Wang Y, Zhao X, et al. Lymphocyte inhibition is compromised in mesenchymal stem cells from psoriatic skin[J]. Eur J Dermatol, 2014,24(5):560⁃567. doi: 10.1684/ejd.2014. 2394.
|
[25] |
Chen H, Niu JW, Ning HM, et al. Treatment of psoriasis with mesenchymal stem cells[J]. Am J Med, 2016,129(3):e13⁃14. doi: 10.1016/j.amjmed.2015.11.001.
|
[26] |
De Jesus MM, Santiago JS, Trinidad CV, et al. Autologous adipose⁃derived mesenchymal stromal cells for the treatment of psoriasis vulgaris and psoriatic arthritis: a case report[J]. Cell Transplant, 2016,25(11):2063⁃2069. doi: 10.3727/096368 916X691998.
|
[27] |
Comella K, Parlo M, Daly R, et al. First⁃in⁃man intravenous implantation of stromal vascular fraction in psoriasis: a case study[J]. Int Med Case Rep J, 2018,11:59⁃64. doi: 10.2147/IMCRJ.S163612.
|
[28] |
Seetharaman R, Mahmood A, Kshatriya P, et al. Mesenchymal stem cell conditioned media ameliorate psoriasis vulgaris: a case study[J]. Case Rep Dermatol Med, 2019,2019:8309103. doi: 10.1155/2019/8309103.
|
[29] |
Mendicino M, Bailey AM, Wonnacott K, et al. MSC⁃based product characterization for clinical trials: an FDA perspective[J]. Cell Stem Cell, 2014,14(2):141⁃145. doi: 10.1016/j.stem. 2014.01.013.
|
[30] |
Tarte K, Gaillard J, Lataillade JJ, et al. Clinical⁃grade production of human mesenchymal stromal cells: occurrence of aneuploidy without transformation[J]. Blood, 2010,115(8):1549⁃1553. doi: 10.1182/blood⁃2009⁃05⁃219907.
|
[31] |
Crowder SW, Horton LW, Lee SH, et al. Passage⁃dependent cancerous transformation of human mesenchymal stem cells under carcinogenic hypoxia[J]. FASEB J, 2013,27(7):2788⁃2798. doi: 10.1096/fj.13⁃228288.
|
[32] |
Lazennec G, Lam PY. Recent discoveries concerning the tumor ⁃ mesenchymal stem cell interactions[J]. Biochim Biophys Acta, 2016,1866(2):290⁃299. doi: 10.1016/j.bbcan.2016.10.004.
|
[33] |
Jung JW, Kwon M, Choi JC, et al. Familial occurrence of pulmonary embolism after intravenous, adipose tissue⁃derived stem cell therapy[J]. Yonsei Med J, 2013,54(5):1293⁃1296. doi: 10.3349/ymj.2013.54.5.1293.
|
[34] |
Furlani D, Ugurlucan M, Ong L, et al. Is the intravascular administration of mesenchymal stem cells safe? Mesenchymal stem cells and intravital microscopy[J]. Microvasc Res, 2009,77(3):370⁃376. doi: 10.1016/j.mvr.2009.02.001.
|
[35] |
Xu XM, Luo H, Rong BB, et al. Management of delayed encephalopathy after CO poisoning: an evidence⁃based narrative review[J]. Medicine (Baltimore), 2019,98(49):e18199. doi: 10. 1097/MD.0000000000018199.
|
[36] |
赵鸣悦, 符粤文, 王倩, 等. 脐血间充质干细胞在难治性重型再生障碍性贫血异基因造血干细胞移植中的应用[J]. 中华血液学杂志, 2019,40(9):726⁃731. doi: 10.3760/cma.j.issn. 0253⁃2727.2019.09.003.
|
[37] |
Jayaraj JS, Janapala RN, Qaseem A, et al. Efficacy and safety of stem cell therapy in advanced heart failure patients: a systematic review with a meta⁃analysis of recent trials between 2017 and 2019[J]. Cureus, 2019,11(9):e5585. doi: 10. 7759/cureus.5585.
|
[38] |
Zhang Y, Chen W, Feng B, et al. The clinical efficacy and safety of stem cell therapy for diabetes mellitus: a systematic review and meta⁃analysis[J]. Aging Dis, 2020,11(1):141⁃153. doi: 10.14336/AD.2019.0421.
|
[39] |
Thompson M, Mei S, Wolfe D, et al. Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: an updated systematic review and meta⁃analysis[J/OL]. E Clinical Medicine, 2020,19:100249[2021⁃03⁃12]. https://www.thelancet.com/journals/eclinm/article/PIIS2589⁃5370(19)30258⁃5/fulltext. doi: 10.1016/ j.eclinm.2019.100249.
|
[40] |
Gu J, Huang L, Zhang C, et al. Therapeutic evidence of umbilical cord⁃derived mesenchymal stem cell transplantation for cerebral palsy: a randomized, controlled trial[J]. Stem Cell Res Ther, 2020,11(1):43. doi: 10.1186/s13287⁃019⁃1545⁃x.
|